The global Transcriptome Sequencing Market is projected to grow from US$ 2742 million in 2025 to US$ 6073 million by 2031, at a Compound Annual Growth Rate (CAGR) of 14.2% during the forecast period.
Transcriptome Sequencing Market – Growth Drivers
Surging Adoption in Precision Medicine
Transcriptome sequencing plays a vital role in developing personalized treatments by identifying disease-specific gene expressions, especially in oncology and rare diseases.
Technological Advancements in RNA-Seq
Innovations in next-generation sequencing (NGS), including single-cell RNA sequencing and long-read platforms, are enhancing accuracy and reducing sequencing costs.
Increased Funding for Genomics Research
Global funding initiatives from government and private sectors—such as the Human Cell Atlas and Cancer Genome Atlas—are driving widespread adoption of transcriptome technologies.
Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5? and 3? terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.
In terms of production side, this report researches the Transcriptome Sequencing production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Transcriptome Sequencing by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Transcriptome Sequencing, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Transcriptome Sequencing, also provides the consumption of main regions and countries. of the upcoming market potential for Transcriptome Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transcriptome Sequencing sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transcriptome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Transcriptome Sequencing sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumina, Thermo Fisher Scientific, Eurofins Scientific, Roche, Bio-Rad, Agilent Technologies, LabCorp, QIAGEN, Pacific Biosciences, Azenta, etc.
Global Transcriptome Sequencing Companies Covered
Illumina, Thermo Fisher Scientific, Eurofins Scientific, Roche, Bio-Rad, Agilent Technologies, LabCorp, QIAGEN, Pacific Biosciences, Azenta, BGI Genomics, Novogene, Macrogen, Shanghai ZJ Bio-Tech, Tsingke Biotechnology
Global Transcriptome Sequencing Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcriptome Sequencing Market, Segment by Type
Coding RNA
Noncoding RNA
Global Transcriptome Sequencing Market, Segment by Application
Biomedical Field
Non-medical Field
Transcriptome Sequencing Market – Recent Developments
Strategic Mergers and Acquisitions
Illumina, Thermo Fisher Scientific, and Eurofins Scientific have expanded capabilities through acquisitions and joint ventures, enhancing service portfolios and global reach.
Launch of High-Throughput Platforms
Companies like Pacific Biosciences and QIAGEN have introduced new platforms focused on long-read and single-cell sequencing, improving data accuracy and throughput.
Clinical Integration of RNA-Seq
Transcriptome sequencing is being increasingly integrated into clinical workflows for diagnostics and biomarker discovery, especially for cancer and infectious diseases.
Transcriptome Sequencing Market – Emerging Trends
Growth of Single-Cell Transcriptomics
Demand for single-cell RNA sequencing is growing rapidly due to its ability to analyze gene expression at the individual cell level, revealing cell heterogeneity in complex tissues.
AI and Bioinformatics Integration
Advanced data analysis powered by AI and machine learning is enabling deeper insights from large transcriptomic datasets, supporting faster interpretation and decision-making.
Expansion into Non-Medical Fields
Transcriptome sequencing is being adopted in agriculture, environmental science, and microbiology for studying gene expression in plants, microbes, and ecosystems.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Transcriptome Sequencing production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Transcriptome Sequencing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Transcriptome Sequencing manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptome Sequencing sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Related Reports:
Global Next-Generation Sequencing Market Size, Share, Trends, Competitive Analysis, Key Players, Growth Opportunities, Revenue Analysis, and Demand Forecast to 2032
DNA Sequencing In Drug Discovery Market Size, Trends, Regional Analysis(Europe, Asia Pacific, America, Middle East And Africa), And Forecasts 2022-2029
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Coding RNA
1.2.3 Noncoding RNA
1.3 Market by Application
1.3.1 Global Transcriptome Sequencing Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptome Sequencing Market Perspective (2020-2031)
2.2 Global Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Transcriptome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transcriptome Sequencing Market Size by Region (2020-2031)
2.3 Transcriptome Sequencing Market Dynamics
2.3.1 Transcriptome Sequencing Industry Trends
2.3.2 Transcriptome Sequencing Market Drivers
2.3.3 Transcriptome Sequencing Market Challenges
2.3.4 Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Transcriptome Sequencing by Players
3.1.1 Global Transcriptome Sequencing Revenue by Players (2020-2025)
3.1.2 Global Transcriptome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transcriptome Sequencing, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Sequencing Revenue in 2024
3.5 Global Key Players of Transcriptome Sequencing Head office and Area Served
3.6 Global Key Players of Transcriptome Sequencing, Product and Application
3.7 Global Key Players of Transcriptome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Transcriptome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Transcriptome Sequencing Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
5.1 Global Transcriptome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Transcriptome Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transcriptome Sequencing Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Transcriptome Sequencing Market Size by Type (2020-2031)
6.2.2 North America Transcriptome Sequencing Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Transcriptome Sequencing Market Size by Application (2020-2031)
6.3.2 North America Transcriptome Sequencing Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Transcriptome Sequencing Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Transcriptome Sequencing Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Transcriptome Sequencing Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Transcriptome Sequencing Market Size by Type (2020-2031)
7.2.2 Europe Transcriptome Sequencing Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Transcriptome Sequencing Market Size by Application (2020-2031)
7.3.2 Europe Transcriptome Sequencing Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Transcriptome Sequencing Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Transcriptome Sequencing Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Transcriptome Sequencing Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Transcriptome Sequencing Market Size by Type (2020-2031)
8.2.2 China Transcriptome Sequencing Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Transcriptome Sequencing Market Size by Application (2020-2031)
8.3.2 China Transcriptome Sequencing Market Share by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Transcriptome Sequencing Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Transcriptome Sequencing Market Size by Type (2020-2031)
9.2.2 Asia Transcriptome Sequencing Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Transcriptome Sequencing Market Size by Application (2020-2031)
9.3.2 Asia Transcriptome Sequencing Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Transcriptome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Transcriptome Sequencing Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in Transcriptome Sequencing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Transcriptome Sequencing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Transcriptome Sequencing Introduction
11.3.4 Eurofins Scientific Revenue in Transcriptome Sequencing Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Transcriptome Sequencing Introduction
11.4.4 Roche Revenue in Transcriptome Sequencing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Transcriptome Sequencing Introduction
11.5.4 Bio-Rad Revenue in Transcriptome Sequencing Business (2020-2025)
11.5.5 Bio-Rad Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Transcriptome Sequencing Introduction
11.6.4 Agilent Technologies Revenue in Transcriptome Sequencing Business (2020-2025)
11.6.5 Agilent Technologies Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Transcriptome Sequencing Introduction
11.7.4 LabCorp Revenue in Transcriptome Sequencing Business (2020-2025)
11.7.5 LabCorp Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Transcriptome Sequencing Introduction
11.8.4 QIAGEN Revenue in Transcriptome Sequencing Business (2020-2025)
11.8.5 QIAGEN Recent Development
11.9 Pacific Biosciences
11.9.1 Pacific Biosciences Company Details
11.9.2 Pacific Biosciences Business Overview
11.9.3 Pacific Biosciences Transcriptome Sequencing Introduction
11.9.4 Pacific Biosciences Revenue in Transcriptome Sequencing Business (2020-2025)
11.9.5 Pacific Biosciences Recent Development
11.10 Azenta
11.10.1 Azenta Company Details
11.10.2 Azenta Business Overview
11.10.3 Azenta Transcriptome Sequencing Introduction
11.10.4 Azenta Revenue in Transcriptome Sequencing Business (2020-2025)
11.10.5 Azenta Recent Development
11.11 BGI Genomics
11.11.1 BGI Genomics Company Details
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics Transcriptome Sequencing Introduction
11.11.4 BGI Genomics Revenue in Transcriptome Sequencing Business (2020-2025)
11.11.5 BGI Genomics Recent Development
11.12 Novogene
11.12.1 Novogene Company Details
11.12.2 Novogene Business Overview
11.12.3 Novogene Transcriptome Sequencing Introduction
11.12.4 Novogene Revenue in Transcriptome Sequencing Business (2020-2025)
11.12.5 Novogene Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen Transcriptome Sequencing Introduction
11.13.4 Macrogen Revenue in Transcriptome Sequencing Business (2020-2025)
11.13.5 Macrogen Recent Development
11.14 Shanghai ZJ Bio-Tech
11.14.1 Shanghai ZJ Bio-Tech Company Details
11.14.2 Shanghai ZJ Bio-Tech Business Overview
11.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Introduction
11.14.4 Shanghai ZJ Bio-Tech Revenue in Transcriptome Sequencing Business (2020-2025)
11.14.5 Shanghai ZJ Bio-Tech Recent Development
11.15 Tsingke Biotechnology
11.15.1 Tsingke Biotechnology Company Details
11.15.2 Tsingke Biotechnology Business Overview
11.15.3 Tsingke Biotechnology Transcriptome Sequencing Introduction
11.15.4 Tsingke Biotechnology Revenue in Transcriptome Sequencing Business (2020-2025)
11.15.5 Tsingke Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Transcriptome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Coding RNA
Table 3. Key Players of Noncoding RNA
Table 4. Global Transcriptome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Transcriptome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Market Size by Region (2020-2031) & (US$ Million)
Table 7. Global Transcriptome Sequencing Market Share by Region (2020-2031)
Table 8. Market Trends
Table 9. Market Drivers
Table 10. Market Challenges
Table 11. Market Restraints
Table 12. Global Transcriptome Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 13. Global Transcriptome Sequencing Market Share by Players (2020-2025)
Table 14. Global Top Transcriptome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024)
Table 15. Global Transcriptome Sequencing Industry Ranking 2023 VS 2024
Table 16. Global 5 Largest Players Market Share by Transcriptome Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 17. Global Key Players of Transcriptome Sequencing, Headquarters and Area Served
Table 18. Global Key Players of Transcriptome Sequencing, Product and Application
Table 19. Global Key Players of Transcriptome Sequencing, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Market Size by Type (2020-2025) & (US$ Million)
Table 22. Global Transcriptome Sequencing Revenue Market Share by Type (2020-2025)
Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 24. Global Transcriptome Sequencing Revenue Market Share by Type (2026-2031)
Table 25. Global Market Size by Application (2020-2025) & (US$ Million)
Table 26. Global Transcriptome Sequencing Revenue Market Share by Application (2020-2025)
Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 28. Global Transcriptome Sequencing Revenue Market Share by Application (2026-2031)
Table 29. North America Market Size by Type (2020-2031) & (US$ Million)
Table 30. North America Market Size by Application (2020-2031) & (US$ Million)
Table 31. North America Transcriptome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Market Size by Country (2020-2031) & (US$ Million)
Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)
Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)
Table 35. Europe Transcriptome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)
Table 37. China Market Size by Type (2020-2031) & (US$ Million)
Table 38. China Market Size by Application (2020-2031) & (US$ Million)
Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)
Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)
Table 41. Asia Transcriptome Sequencing Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)
Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
Table 45. Middle East, Africa, and Latin America Transcriptome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
Table 47. Illumina Company Details
Table 48. Illumina Business Overview
Table 49. Illumina Transcriptome Sequencing Product
Table 50. Illumina Revenue (2020-2025) & (US$ Million)
Table 51. Illumina Recent Development
Table 52. Thermo Fisher Scientific Company Details
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Transcriptome Sequencing Product
Table 55. Thermo Fisher Scientific Revenue (2020-2025) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Eurofins Scientific Company Details
Table 58. Eurofins Scientific Business Overview
Table 59. Eurofins Scientific Transcriptome Sequencing Product
Table 60. Eurofins Scientific Revenue (2020-2025) & (US$ Million)
Table 61. Eurofins Scientific Recent Development
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Transcriptome Sequencing Product
Table 65. Roche Revenue (2020-2025) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Bio-Rad Company Details
Table 68. Bio-Rad Business Overview
Table 69. Bio-Rad Transcriptome Sequencing Product
Table 70. Bio-Rad Revenue (2020-2025) & (US$ Million)
Table 71. Bio-Rad Recent Development
Table 72. Agilent Technologies Company Details
Table 73. Agilent Technologies Business Overview
Table 74. Agilent Technologies Transcriptome Sequencing Product
Table 75. Agilent Technologies Revenue (2020-2025) & (US$ Million)
Table 76. Agilent Technologies Recent Development
Table 77. LabCorp Company Details
Table 78. LabCorp Business Overview
Table 79. LabCorp Transcriptome Sequencing Product
Table 80. LabCorp Revenue (2020-2025) & (US$ Million)
Table 81. LabCorp Recent Development
Table 82. QIAGEN Company Details
Table 83. QIAGEN Business Overview
Table 84. QIAGEN Transcriptome Sequencing Product
Table 85. QIAGEN Revenue (2020-2025) & (US$ Million)
Table 86. QIAGEN Recent Development
Table 87. Pacific Biosciences Company Details
Table 88. Pacific Biosciences Business Overview
Table 89. Pacific Biosciences Transcriptome Sequencing Product
Table 90. Pacific Biosciences Revenue (2020-2025) & (US$ Million)
Table 91. Pacific Biosciences Recent Development
Table 92. Azenta Company Details
Table 93. Azenta Business Overview
Table 94. Azenta Transcriptome Sequencing Product
Table 95. Azenta Revenue (2020-2025) & (US$ Million)
Table 96. Azenta Recent Development
Table 97. BGI Genomics Company Details
Table 98. BGI Genomics Business Overview
Table 99. BGI Genomics Transcriptome Sequencing Product
Table 100. BGI Genomics Revenue (2020-2025) & (US$ Million)
Table 101. BGI Genomics Recent Development
Table 102. Novogene Company Details
Table 103. Novogene Business Overview
Table 104. Novogene Transcriptome Sequencing Product
Table 105. Novogene Revenue (2020-2025) & (US$ Million)
Table 106. Novogene Recent Development
Table 107. Macrogen Company Details
Table 108. Macrogen Business Overview
Table 109. Macrogen Transcriptome Sequencing Product
Table 110. Macrogen Revenue (2020-2025) & (US$ Million)
Table 111. Macrogen Recent Development
Table 112. Shanghai ZJ Bio-Tech Company Details
Table 113. Shanghai ZJ Bio-Tech Business Overview
Table 114. Shanghai ZJ Bio-Tech Transcriptome Sequencing Product
Table 115. Shanghai ZJ Bio-Tech Revenue (2020-2025) & (US$ Million)
Table 116. Shanghai ZJ Bio-Tech Recent Development
Table 117. Tsingke Biotechnology Company Details
Table 118. Tsingke Biotechnology Business Overview
Table 119. Tsingke Biotechnology Transcriptome Sequencing Product
Table 120. Tsingke Biotechnology Revenue (2020-2025) & (US$ Million)
Table 121. Tsingke Biotechnology Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transcriptome Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 2. Global Transcriptome Sequencing Market Share by Type: 2024 VS 2031
Figure 3. Coding RNA Features
Figure 4. Noncoding RNA Features
Figure 5. Global Transcriptome Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Global Transcriptome Sequencing Market Share by Application: 2024 VS 2031
Figure 7. Biomedical Field Case Studies
Figure 8. Non-medical Field Case Studies
Figure 9. Transcriptome Sequencing Report Years Considered
Figure 10. Global Transcriptome Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Transcriptome Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Transcriptome Sequencing Market Share by Region: 2024 VS 2031
Figure 13. Global Transcriptome Sequencing Market Share by Players in 2024
Figure 14. Global Top Transcriptome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Transcriptome Sequencing Revenue in 2024
Figure 16. North America Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 17. North America Transcriptome Sequencing Market Share by Type (2020-2031)
Figure 18. North America Transcriptome Sequencing Market Share by Application (2020-2031)
Figure 19. North America Transcriptome Sequencing Market Share by Country (2020-2031)
Figure 20. United States Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transcriptome Sequencing Market Share by Type (2020-2031)
Figure 24. Europe Transcriptome Sequencing Market Share by Application (2020-2031)
Figure 25. Europe Transcriptome Sequencing Market Share by Country (2020-2031)
Figure 26. Germany Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. China Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. China Transcriptome Sequencing Market Share by Type (2020-2031)
Figure 34. China Transcriptome Sequencing Market Share by Application (2020-2031)
Figure 35. Asia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia Transcriptome Sequencing Market Share by Type (2020-2031)
Figure 37. Asia Transcriptome Sequencing Market Share by Application (2020-2031)
Figure 38. Asia Transcriptome Sequencing Market Share by Region (2020-2031)
Figure 39. Japan Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. China Taiwan Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Type (2020-2031)
Figure 47. Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Application (2020-2031)
Figure 48. Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Country (2020-2031)
Figure 49. Brazil Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Mexico Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Turkey Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Israel Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. GCC Countries Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Illumina Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 57. Eurofins Scientific Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 58. Roche Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 59. Bio-Rad Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 60. Agilent Technologies Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 61. LabCorp Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 62. QIAGEN Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 63. Pacific Biosciences Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 64. Azenta Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 65. BGI Genomics Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 66. Novogene Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 67. Macrogen Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 68. Shanghai ZJ Bio-Tech Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 69. Tsingke Biotechnology Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.